Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Integrated biomarker profiling of the metabolome associated with impaired fasting glucose and type 2 diabetes mellitus in large-scale Chinese patients.

  • Authors : Long J; Beijing Friendship Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory for Evaluation of Rational Drug Use, Beijing, China.

Subjects: Biomarkers/Biomarkers/Biomarkers/*analysis ; Blood Glucose/Blood Glucose/Blood Glucose/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*diagnosis

  • Source: Clinical and translational medicine [Clin Transl Med] 2021 Jun; Vol. 11 (6), pp. e432.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Using data on biomarkers and siblings to study early-life economic determinants of type-2 diabetes.

  • Authors : Alessie RJM; University of Groningen, Groningen, The Netherlands.; Netspar, Tilburg, The Netherlands.

Subjects: Diabetes Mellitus, Type 2* ; Siblings* ; Biomarkers*/Biomarkers*/Biomarkers*/blood

  • Source: Health economics [Health Econ] 2024 Jun; Vol. 33 (6), pp. 1266-1283. Date of Electronic Publication: 2024 Feb 25.Publisher: Wiley Country of Publication: England NLM ID: 9306780 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

One-hour post-load glucose and subclinical left atrial myocardial dysfunction in hypertensive patients.

  • Authors : Miceli S; Department of Medical and Surgical Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.; Cassano V

Subjects: Diabetes Mellitus, Type 2* ; Atrial Fibrillation* ; Hypertension*

  • Source: European journal of clinical investigation [Eur J Clin Invest] 2023 Sep; Vol. 53 (9), pp. e14009. Date of Electronic Publication: 2023 May 05.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The role of selected nutraceuticals in management of prediabetes and diabetes: An updated review of the literature.

  • Authors : Derosa G; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.; Centre of Diabetes, Metabolic Diseases, and Dyslipidemias, University of Pavia, Pavia, Italy.

Subjects: Curcumin*/Curcumin*/Curcumin*/pharmacology ; Curcumin*/Curcumin*/Curcumin*/therapeutic use ; Diabetes Mellitus*

  • Source: Phytotherapy research : PTR [Phytother Res] 2022 Oct; Vol. 36 (10), pp. 3709-3765. Date of Electronic Publication: 2022 Aug 01.Publisher: Wiley Country of Publication: England NLM ID: 8904486 Publication Model: Print-Electronic Cited Medium:

Record details

×
Report

Human and mouse non-targeted metabolomics identify 1,5-anhydroglucitol as SGLT2-dependent glycemic marker.

  • Authors : Kappel BA; Department of Internal Medicine 1, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.; Moellmann J

Subjects: Metabolome*; Biomarkers/Biomarkers/Biomarkers/*metabolism ; Deoxyglucose/Deoxyglucose/Deoxyglucose/*metabolism

  • Source: Clinical and translational medicine [Clin Transl Med] 2021 Jun; Vol. 11 (6), pp. e470.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Studies on the serological markers for hepatitis B virus infection among type 2 diabetic patients.

  • Authors : Ndako JA; Department of Microbiology, Landmark University, Omu-Aran, Nigeria.; Nwankiti OO

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Hepatitis B*/Hepatitis B*/Hepatitis B*/blood

  • Source: Journal of clinical laboratory analysis [J Clin Lab Anal] 2021 Jan; Vol. 35 (1), pp. e23464. Date of Electronic Publication: 2021 Jan 07.Publisher: Wiley Country of Publication: United States NLM ID: 8801384 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21.

  • Authors : Zarei M; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, Spain.; Spanish Biomedical Research Center in Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Fibroblast Growth Factors/Fibroblast Growth Factors/Fibroblast Growth Factors/*metabolism ; Glucose Intolerance/Glucose Intolerance/Glucose Intolerance/*drug therapy

  • Source: British journal of pharmacology [Br J Pharmacol] 2019 Jul; Vol. 176 (13), pp. 2292-2305. Date of Electronic Publication: 2019 May 23.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The efficacy of propolis on markers of glycemic control in adults with type 2 diabetes mellitus: A systematic review and meta-analysis.

  • Authors : Karimian J; Department of General Courses, School of Management and Medical Information Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.; Hadi A

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Phytotherapy research : PTR [Phytother Res] 2019 Jun; Vol. 33 (6), pp. 1616-1626. Date of Electronic Publication: 2019 Apr 05.Publisher: Wiley Country of Publication: England NLM ID: 8904486 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.

  • Authors : Moelands SV; Department of Primary and Community Care, Radboud University Nijmegen Medical Center, PO Box 9101, Nijmegen, Netherlands, 6500 HB.; Lucassen PL

Subjects: Acarbose/Acarbose/Acarbose/*therapeutic use ; Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*prevention & control

  • Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2018 Dec 28; Vol. 12. Cochrane AN: CD005061. Date of Electronic Publication: 2018 Dec 28.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus.

  • Authors : Zhao C; Department of Endocrinology, Zhongshan Hospital, Fudan University, Shanghai, China.; Liu G

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Bone Density/Bone Density/Bone Density/*physiology ; Bone Remodeling/Bone Remodeling/Bone Remodeling/*physiology

  • Source: Journal of clinical laboratory analysis [J Clin Lab Anal] 2020 Apr; Vol. 34 (4), pp. e23112. Date of Electronic Publication: 2019 Nov 15.Publisher: Wiley Country of Publication: United States NLM ID: 8801384 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  1,897 results for ""Diabetes Mellitus, Type 2""